Literature DB >> 8024260

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.

D J Meyerhoff1, S MacKay, J M Constans, D Norman, C Van Dyke, G Fein, M W Weiner.   

Abstract

We used spin-echo magnetic resonance imaging and proton magnetic resonance spectroscopic imaging in 8 patients with probable Alzheimer's disease and in 10 age-matched elderly control subjects to assess the effects of Alzheimer's disease on the brain. On magnetic resonance images the patients showed significant ventricular enlargements relative to the control subjects. We measured the distribution and relative signal intensities of N-acetylaspartate (a putative neuronal marker), of choline residues representing lipid metabolites, and of creatine-containing metabolites in a large section of the centrum semiovale containing white and mesial gray matter. Throughout the white matter of the patients with Alzheimer's disease compared to elderly control subjects, N-acetylaspartate was decreased relative to choline (N-acetylaspartate-choline ratio) and creatine-containing metabolites (N-acetylaspartate-creatine ratio) with no changes in the choline-creatine ratio. The N-acetylaspartate-choline ratio was lower and choline-creatine higher in the mesial gray matter of AD patients relative to elderly controls. The posterior section of the centrum semiovale in the patients showed increased choline-creatine and choline-N-acetylaspartate ratios with the N-acetylaspartate-creatine ratio unchanged between the patients and control subjects. These spectroscopic findings give suggestive evidence of diffuse axonal injury and membrane alterations in gray and white matter of the centrum semiovale in patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024260     DOI: 10.1002/ana.410360110

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  43 in total

Review 1.  Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.

Authors:  Giovanni B Frisoni; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

2.  Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.

Authors:  Pedro J Modrego; Miguel A Pina; Nicolás Fayed; Marcos Díaz
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

Review 4.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

Review 5.  Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Authors:  Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner
Journal:  J Rehabil Res Dev       Date:  2009

6.  Development and aging of the cerebrum: assessment with proton MR spectroscopy.

Authors:  T Kadota; T Horinouchi; C Kuroda
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

7.  Aberrant regulation of choline metabolism by mitochondrial electron transport system inhibition in neuroblastoma cells.

Authors:  Ahmet T Baykal; Mohit R Jain; Hong Li
Journal:  Metabolomics       Date:  2008-12-01       Impact factor: 4.290

8.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Authors:  Kejal Kantarci; David S Knopman; Dennis W Dickson; Joseph E Parisi; Jennifer L Whitwell; Stephen D Weigand; Keith A Josephs; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

Review 9.  Proton MRS in mild cognitive impairment.

Authors:  Kejal Kantarci
Journal:  J Magn Reson Imaging       Date:  2013-04       Impact factor: 4.813

10.  Alzheimer's Disease, Diagnosis and the Need for Biomarkers.

Authors:  Claudie Hooper; Simon Lovestone; Ricardo Sainz-Fuertes
Journal:  Biomark Insights       Date:  2008-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.